SCHEMBL8226264

SCHEMBL8226264

CCCc1ccc2ncnn2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.41
MET P08581 1/20 0.39
SCN5A Q14524 1/20 0.39
TGFBR1 P36897 7/20 0.38
NAMPT P43490 1/20 0.35
TNIK Q9UKE5 1/20 0.35
SLC5A2 P31639 1/20 0.35
MAPK14 Q16539 2/20 0.33
AKR1C4 P17516 1/20 0.33
AKR1C3 P42330 1/20 0.33
AKR1C2 P52895 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33
TLR9 Q9NR96 1/20 0.33
TLR8 Q9NR97 1/20 0.33
TLR7 Q9NYK1 1/20 0.33
PIK3CD O00329 1/20 0.33
ACVRL1 P37023 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8178921 0.85 SCN5A (0.44) DYRK1AMETSCN5ATGFBR1NAMPT
SCHEMBL25124479 0.74 DYRK1A (0.41) DYRK1ASCN5ATGFBR1MAPK14
SCHEMBL25410704 0.72 NAMPT (0.41) DYRK1ASCN5ANAMPTSLC5A2AKR1C4
SCHEMBL25436056 0.71 CYP4F2 (0.44) DYRK1AMETSCN5ATGFBR1NAMPT
SCHEMBL20193870 0.71 SCN5A (0.39) DYRK1AMETSCN5ATGFBR1MAPK14
SCHEMBL21366673 0.70 DYRK1A (0.41) DYRK1AMETSCN5ATGFBR1MAPK14
SCHEMBL23128004 0.70 DYRK1A (0.38) DYRK1AMETSCN5ATGFBR1NAMPT
SCHEMBL25726216 0.70 DYRK1A (0.38) DYRK1ASCN5ATGFBR1MAPK14TLR9
SCHEMBL25415202 0.69 DRD2 (0.43) SLC5A2MGLL
SCHEMBL22388591 0.69 SCN5A (0.40) DYRK1AMETSCN5ATGFBR1MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007139856-A2 HETEROBICYCLIC METALLOPROTEASE INHIBITORS ALANTOS PHARMACEUTICALS, INC. (US) 2007-12-06 WO disclosed
WO-2007139860-A2 HETEROBICYLIC METALLOPROTEASE INHIBITORS ALANTOS PHARMACEUTICALS, INC. (US) 2007-12-06 WO disclosed